New Orleans, December 8 – PharmID, a leader in controlled substance waste verification, is proud to announce a new partnership with HelioMetrics, a premier provider of diversion analytics software. This collaboration integrates PharmID’s innovative WasteWitness waste verification solution with HelioMetrics’ advanced analytics, creating a seamless and comprehensive approach to controlled substance management across healthcare settings.

Through this integration, WasteWitness will provide verified waste data directly into HelioMetrics’ analytics platform, enabling a closed-loop solution that offers healthcare organizations a more complete view of their controlled substance workflows. By combining WasteWitness data with HelioMetrics’ detailed analytics, hospitals and healthcare providers gain enhanced capabilities to monitor and verify the entire chain of custody for controlled substances, ensuring compliance and improving safety.

“The collaboration with HelioMetrics brings us closer to our vision of fully integrated, end-to-end controlled substance management,” said James DePoy, CEO, PharmID. “By incorporating WasteWitness data with HelioMetrics’ diversion analytics, we are helping healthcare providers not only to validate substance disposal but also to detect potential diversion at multiple points in the process. Together, we are setting a new standard for security and accountability in controlled substance management.”

HelioMetrics’ robust diversion analytics platform analyzes controlled substance data to help healthcare providers quickly identify and respond to potential risks and areas of vulnerability. WasteWitness by PharmID adds to this by offering real-time verification of drug type, concentration, and volume during the waste process. The resulting integration delivers a powerful tool to help organizations maintain high standards of compliance and patient safety.

“We’re thrilled to integrate WasteWitness data into our platform,” said Jeremy Wunsch, Founder and CTO HelioMetrics. “PharmID’s approach to waste verification aligns perfectly with our mission to provide healthcare facilities with actionable insights that help prevent and reduce diversion. With WasteWitness data, our customers gain an unprecedented level of assurance, from initial dispensing to final waste, strengthening the controlled substance management cycle.”

This partnership comes at a critical time when healthcare facilities are prioritizing controlled substance oversight more than ever. With the WasteWitness and HelioMetrics integration, healthcare organizations have access to a comprehensive solution for improving transparency, enforcing accountability, and reducing the risk of controlled substance diversion in the healthcare system.

For more information on this partnership and how it can benefit your organization, please visit https://www.pharmid.com or https://heliometrics.net.

About HelioMetrics

HelioMetrics® leads the industry in drug diversion analytics, offering intuitive design, rigorous data validation, customizable visualizations, and seamless integration. Our platform ensures unmatched accuracy in detecting and preventing diversion, delivering compliance, process improvement, and actionable insights—all from one trusted, comprehensive solution.

About PharmID

PharmID, headquartered in Kirkland, WA, is a pioneering provider of cutting-edge solutions for controlled substance management, dedicated to enhancing safety, compliance, and efficiency in healthcare. Through its innovative WasteWitness® system and other advanced technologies, PharmID supports hospitals, pharmacies, and healthcare organizations nationwide in preventing diversion, ensuring regulatory compliance, and safeguarding patient safety. For more information on PharmID and the WasteWitness® system, visit pharmid.com.

Contact:

Robb Young | Head of Partnerships | robby@pharmid.com